Institutional investors purchased a net $8.3 million shares of GERN during the quarter ended June 2019 and now own 50.71% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 325.6 Thousand shares of Geron Corp
KLP KAPITALFORVALTNING AS Bought 26.2 Thousand shares of Geron Corp
IRISH LIFE INVESTMENT MANAGERS L... Bought 8.8 Thousand shares of Geron Corp